Maximilian Molitor und Vernall - Info zur Person

(1 - 6 von 7

)

from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic ...ACS Publications

pubs.acs.org

von F Gado · · Zitiert von: 12 — ... Raahul Sharma, Sameek Singh, Zak M. Whiting, Maximilian Molitor, Andrea J. Vernall, Natasha L. Grimsey. Novel Cannabinoid Receptor

Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity ...MDPI

mdpi-res.com

von R Sharma · · Zitiert von: 2 — Maximilian Molitor 3,5. , Andrea J. Vernall 3,6 and Natasha L. Grimsey 1,2,6,*. 1. Department of Pharmacology and Clinical Pharmacology, ...

Create a SciFeed alert for new publicationsMDPI

www.mdpi.com

By following authors. Raahul Sharma. Sameek Singh. Zak M. Whiting. Maximilian Molitor. Andrea J. Vernall. Natasha L. Grimsey ...

Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity ...National Institutes of Health (.gov)

pubmed.ncbi.nlm.nih.gov

von R Sharma · · Zitiert von: 2 — Authors. Raahul Sharma , Sameek Singh , Zak M Whiting , Maximilian Molitor , Andrea J Vernall , Natasha L Grimsey ...

Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity ...University of Auckland

researchspace.auckland.ac.nz

von R Sharma · · Zitiert von: 2 — Maximilian Molitor 3,5. , Andrea J. Vernall 3,6 and Natasha L. Grimsey 1,2,6,*. 1. Department of Pharmacology and Clinical Pharmacology, ...